|Articles|February 1, 2012
- Pharmaceutical Executive-02-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2012
Brand of the Year : Abbott's Humira
Advertisement
Articles in this issue
over 14 years ago
How to Choose a Medical Animatorover 14 years ago
Money for Nothing, Patents for Free?over 14 years ago
Trying Trials at GC-2over 14 years ago
Prizing the Eye : Brent Saunders, CEO Bausch + Lombover 14 years ago
Brand Success: It's Not Serendipityover 14 years ago
Brazil Report: A Bold Player Bloomsover 14 years ago
Of Farms, Beaches … and Genericsover 14 years ago
FDA Social Media Guidelines: Irresponsible?over 14 years ago
Time to Appoint a 'Chief Patient Officer'?over 14 years ago
Japanese Knowledge Brought to BrazilAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan
2
Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics
3
FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease
4
Educating Patients About GLP-1s: Q&A with Kristen Hartzell, PharmD
5